🇺🇸 FDA
Patent

US 7897617

Quinuclidine derivatives and medicinal compositions containing the same

granted A61KA61K31/439A61K31/4745

Quick answer

US patent 7897617 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall Prodesfarma S.A. expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06